E-News | 03/06/2021 11:30 AM | Click to read full article
All India Institute of Medical Sciences (AIIMS), Patna has started paediatric trials of Bharat Biotech’s Covaxin. Meanwhile, the Centre on Tuesday warned that COVID-19 can have an increased impact on children if the virus changes behavior.
COVID-19 in children is often asymptomatic and rarely requires hospitalization. However, changes in epidemiological dynamics can change the situation and increase the prevalence of infection. No undue burden has been placed on the paediatric care infrastructure so far.